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AbstractGeneralized	anxiety	disorder	(GAD)	involves	dysregulation	of	worry	for	more	than	6	months.	Symptoms	include	fatigue,	insomnia	and	irritability.	Medications	such	as	SSRIs	may	cause	constipation,	lower	libido	and	cause	withdrawal	symptoms	when	discontinued.	Alternative	therapies	like	mindfulness	meditation	teach	patients	breath	awareness	and	to	redirect	unwanted	negative	thoughts	to	positive	ones.	This	paper	examines	the	efficacy	of	mindfulness	meditation	treatment	(I)	for	managing	symptoms	of	anxiety	(O)	in	adult	patients	with	mild-moderate	GAD	(P)	in	comparison	to	stress	management	education	(C).	
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Introduction
MethodsLiterature	search
ØPerformed	in	October	2018	using:	1)		Google	scholar.										2)	PubMed 3)Ovid
ØSearch	terms:	mindfulness	meditation	AND	generalized	anxiety	disorder	AND	stress	management	education’
ØInclusion	criteria:
oPublished	2013	or	later
oWritten	in	English
oRandomized	control	trials	with	human	test	subjects,	clinical	trials	and	those	that	were	reviewed
ØExclusion	criteria:
oStudies	that	involved	clinical	trials	with	animals
oStudies	that	did	not	include	a	clinical	trial
oClinical	trials	involving	adolescents	younger	than	18	years	of	age
oStudies	that	included	an	anxiety	disorder	that	was	not	GAD
oStudies	involving	PTSD	with	anxiety
6/6	studies	report	significant	improvement	in	anxiety	symptoms	from	the	use	
of	mindfulness-based	meditation	in	patients	diagnosed	with	generalized	
anxiety	disorder	(GAD).	5/6	studies	show	significant	difference	between	
treatment	and	control	groups	(Wong’s	study	is	the	only	one	that	didn’t)	Strengths
ØAll	studies	were	based	on	RCTà unbiased	distribution	improving	credibility	of	studies
ØStatistically	significant	resultsàp	value<0.05
ØAdequate	treatment	timeline	à >8	weeks
ØNo	study	reported	any	adverse	effect	of	mindfulness	meditation	treatmentLimitations
ØLimited	monitoring	of	home-based	meditation	exercises
ØDrop	outs	in	4/6	studies	and	inadequate	follow	up
ØRecruitment	methods
ØGender	distribution	Future	Research
ØUtilize	web-cam	with	live	monitoring	of	home	meditation	exercises
ØMindfulness	meditation	as	an	adjunct	therapy	to	pharmaceutical	therapy	with	SSRIs
ØSynergistic	effects	of	psychotherapy	and	mindfulness	meditation	
Discussion
Note:	*p=.005
Results
Mindfulness	meditation	as	a	treatment	for	Generalized	Anxiety	
Disorder	(GAD)
The	study	results	are	promising,	however	more	research	with	
improvements	in	experimental	design	are	necessary	to	make	a	definitive	conclusion.	Studies	suggest	that	mindfulness	meditation	may	be	effectivein	treating	patients	diagnosed	with	generalized	anxiety	disorder	especially	those	with	complicated	comorbidities,	side	effects	or	allergies.
However	difficult	to	conclude	that	it	can	be	used	as	an	alternative to	pharmaceutical	therapy	as	there	is	no	study	that	makes	a	direct	
comparison between	the	two.	More	research	is	necessary	to	determine	whether	symptom	relief	from	meditation	can	be	sustained	for	long	term	anxiety	management	(>6	months).	
Future	studies	should	aim	to	directly	compare	pharmaceutical	therapy	with	mindfulness	meditation	therapy.		Another	possibility	is	to	compare	the	synergistic	effects	of	psychotherapy	and	mindfulness	meditation	with	pharmaceutical	therapy	with	SSRImedication.			
Overall,	results	of	the	meta-analysis	are	positive,	but	the	evidence	is	
insufficient	to	justify	any	changes	to	clinical	practice.	
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Overview:	
ØDysregulation	of	worry	
ØLeads	to	recurrent	activation	of	brain	regions	responsible	for	mental	tasks
ØTwin	studies	suggest	that	both	genetic	and	environmental	factors	are	involved
Ø6%	of	the	population	living	in	the	US	have	a	lifetime	prevalence	of	this	disorderSymptoms
Øinclude	fatigue,	irritability,	nervousness,	insomnia,	and	muscle	tension
ØAssociated	with	depression,	bipolar	disorder	and	substance	use	disorderTreatment
ØFirst	line	treatments	include	SSRIs	and	psychotherapy
ØStress	management	education	(SME)	educates	patients	on	stress	physiology,	optimal		nutrition	and	cultivating	resilience
ØMindfulness	meditation	has	been	studied	as	a	possible	alternative/adjunct.	incorporates	breathing	exercises	and	conscious	awareness	of	breath	
ØUsing	the	body’s	mechanics	:	Deep	breathing	exercises	stimulate	the	vagus nerve
Study Design Total	
N
Population	
Demographi
cs
Disease	at	
Baseline
Control Tx Regimen Outcome	
Measure
Hoge,	Bui,	Palitz et	al	(2018)	 RCT 72 34	females38	males*2	failed	to	complete	study
DSM	IV	GAD SME 1	session	per	week	x	8	weeks=	8	sessions
Cortisol,	ACTH,	IL-6,	TNF-alpha
Hoge,	Guidos,	Mete	et	al	(2017)
RCT 57 32	females25	males DSM	IV	GAD SME 1	session	per	week	x	8	weeks=	8	sessions
#	of	missed	work	days,	#	of	health	professional	visitsHoge,	Bui,	Marques	et	al	(2015)
RCT 38 21	females17	males DSM	IV	GAD	 SME 1	session	per	week	x	8	weeks=	8	sessions Decentering,	BAI,	PSWQHoge	et	al	(2013) RCT	 93 45	females44	males*4	failed	to	complete	study
DSM	IVGAD SME 1	session	per	week	x	8	weeks=	8	sessions
HAM-A,	CGI-S,	CGI-I,	BAI,	TSST
Boettcher	et	al	(2014) RCT 91 65	females26		males GAD Psychoeducation 6	sessions	per	week	x	8	weeks	=	48	sessions
BAI
Wong	et	al	(2016) RCT 182 144	females38	males DSM	IV	GAD Psychoeducation 1	session	per	week	x	8	weeks=	8	sessions
BAI,	PSWQ
Key:	RCT:	Randomized	Control	TrialGAD:	General	Anxiety	DisorderGAD	7:	Generalized	Anxiety	Disorder	7-item	scaleSME:	Stress	management	education,	DSM	IV:	Diagnostic	and	Statistical	Manual	of	Mental	DisordersACTH:	Adrenocorticotropic	hormoneIL-6:	Interleukin-6TNF-alpha:	Tumor	necrosis	factor-alpha	PSWQ:	Penn	State	Worry	QuestionnaireFFMQ:	Five	Facet	Mindfulness	QuestionnaireTSST:	Trier	social	stress testHAM-A:	Hamilton	Anxiety	Rating	ScaleCGI-S:	Clinical	Global	Impression	– Severity	scaleCGI-I:	Clinical	Global	Impression	– Improvement	scaleBAI:	Beck	Anxiety	Inventory	
